Indapamide Sr Genoptim (Indapamide)

Indapamide acts on the distal convoluted tubule of the kidney, blocking the sodium‑chloride cotransporter. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of these ions together with water. The resulting decrease in blood volume and peripheral resistance lowers blood pressure and diminishes edema.

The specific dose of Indapamide Sr Genoptim is determined by the prescribing healthcare professional based on the patient’s medical condition, age, renal function, and response to therapy. The prescriber will select the appropriate strength and dosing schedule that best meets the individual’s therapeutic needs.

Safety data for indapamide in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative options with their healthcare provider.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class, which primarily reduces blood pressure by promoting sodium and water excretion. Compared with ACE inhibitors or calcium‑channel blockers, indapamide may be less effective as monotherapy for severe hypertension but is often combined with those agents to achieve better control and to counteract fluid retention.

Indapamide Sr Genoptim should be stored at temperatures below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Indapamide Sr Genoptim is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and whether it should be taken in the morning to reduce the likelihood of nocturnal urination.

The most serious risks include severe dehydration, marked electrolyte disturbances such as low potassium (hypokalemia) or low sodium (hyponatremia), acute gout attacks, and rare blood disorders like leukopenia or thrombocytopenia. Patients should report symptoms such as muscle weakness, irregular heartbeat, severe dizziness, or unexplained bruising to their clinician promptly.

Indapamide Sr Genoptim is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide-derived diuretics, severe renal impairment, anuria, or uncontrolled electrolyte imbalances. Individuals with a history of gout or those taking lithium should use it only under close medical supervision.